Related Experiment Video

Updated: Jul 19, 2026

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma

Paula Lázcoz1, Jorge Muñoz, Manuel Nistal

  • 1Departamento de Ciencias de la Salud, Universidad Pública de Navarra, Pamplona, Spain. paula.lazcoz@unavarra.es

BMC Cancer
|October 27, 2006
PubMed
Abstract

Insights

Epigenetic silencing of RASSF1A and CASP8 occurs frequently in neuroblastoma tumors. Loss of heterozygosity at 3p21 is rare in these tumors, suggesting other regions harbor key tumor suppressor genes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Epigenetic alterations and loss of heterozygosity (LOH) are key mechanisms for tumor suppressor gene inactivation.
  • RAS effector pathways, including RASSF1A and NORE1A, are implicated in cancer development.
  • RASSF1A (3p21.3) and NORE1A (1q32.1) are critical RAS effector genes.

Purpose of the Study:

  • To investigate LOH and hypermethylation of RASSF1A, NORE1A, and BLU in neuroblastic tumors.
  • To correlate these epigenetic changes with CASP8 hypermethylation and gene expression.
  • To identify potential tumor suppressor genes in neuroblastoma pathogenesis.

Main Methods:

  • Screening of the 3p21 locus for LOH and hypermethylation of RASSF1A, NORE1A, and BLU in 41 neuroblastic tumors.
  • Statistical correlation analysis with CASP8 hypermethylation.
  • Gene expression analysis using RT-PCR in cell lines.

Main Results:

  • LOH and microsatellite instability detected in 14% of tumors at 3p21.
  • High frequency of RASSF1A (83%) and CASP8 (60%) promoter hypermethylation in tumors.
  • Significant association found between RASSF1A and CASP8 hypermethylation; no association with MYCN amplification or 1p deletion.

Conclusions:

  • LOH at 3p21 is infrequent in neuroblastomas, suggesting tumor suppressor genes are not primarily located in this region.
  • Promoter hypermethylation of RASSF1A and CASP8 is a common event in neuroblastomas.
  • Epigenetic silencing of RASSF1A and CASP8 may play a significant role in neuroblastoma development.

More Related Videos

Methyl-binding DNA capture Sequencing for Patient Tissues08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...